NCPDP President & CEO Lee Ann Stember Announces Plans to Retire After 46 Years of Leadership

Résumé détaillé

Stember will retire June 1, 2027, following an extraordinary career advancing healthcare standards, interoperability, and industry collaboration SCOTTSDALE, Ariz., Nov. 11, 2026…

Stember will retire June 1, 2027, following an extraordinary career advancing healthcare standards, interoperability, and industry collaboration

SCOTTSDALE, Ariz., Nov. 11, 2026 /PRNewswire/ -- The National Council for Prescription Drug Programs (NCPDP) today announced that President & CEO Lee Ann Stember intends to retire on June 1, 2027, following 46 years of service and leadership to NCPDP and the healthcare industry. Stember shared her decision with the NCPDP Compensation Committee, Board of Trustees, and Executive Management Team during the November Workgroup Meeting in Portland.

The announcement comes as NCPDP prepares to enter its 50th anniversary year, a milestone that provides a meaningful opportunity to reflect on the organization's evolution, its contributions to healthcare, and the individuals who have helped shape its mission and impact.

"This is a bittersweet decision for me," said Stember. "NCPDP has been far more than the place where I have worked. It has been a community, a shared mission, and an extraordinary opportunity to help shape meaningful change in healthcare. As I reflect on this journey, I am filled with pride in what we have accomplished together, gratitude for the people who made it possible, and optimism for the future."

Throughout her tenure, Stember has helped guide NCPDP through tremendous advances and uncharted territory in health information technology and interoperability. Working alongside NCPDP members, volunteers, staff, board leaders, industry partners, and other collaborators, she has championed consensus-based solutions, strengthened connections among stakeholders with differing perspectives, and supported the advancement of standards that improve care delivery and reduce administrative burdens.

Under Stember's leadership, NCPDP has continued to serve as a trusted convener and an important industry voice as healthcare technology, interoperability, and patient expectations have evolved.

"The progress we have made gives me every…

Début de l'article, extrait de PR Newswire. Pour lire la suite, ouvrez l'article chez le média.